Organovo Logo     Print Page | Close Window

Investor Overview

Who is Organovo?
  • We participate in attractive and growing markets with critical unmet needs
  • We benefit from favorable competitive dynamics and a first mover advantage
  • We’re a technology leader with a strong IP portfolio
  • We’re leveraging our technology platform to build a robust product and service platform across the high-value drug profiling and therapeutic tissues markets
2017 Annual Report Investor Fact Sheet Investor Presentation

Stock Information
ONVO (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) + 0.02 (1.02%)
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: ONVO.O.  Currently trading at $1.99 with a 52 week high of $4.14 and a 52 week low of $1.75.
Recent Investor News
Organovo Sponsors Pioneering Research With Amgen and Medikine in Critical Areas of Liver and Kidney Disease
Organovo Announces Fiscal First-Quarter 2018 Results; Company Affirms Full-Year Fiscal 2018 Outlook
Investor Events
There are currently no events scheduled.
Featured Reports
2017 Annual Report
2017 Proxy Statement
Latest Tweets